Patient care & clinical trials

Addenbrooke’s Hospital is a national and regional centre for many cancer types, including lung cancer treatment at Papworth Hospital. We see around 6,000 new patients each year providing the highest quality clinical care backed up by some of the finest cancer science in the world. The 5 year survival rates for our patients are better than the national average for prostate, oesophageal, pancreatic and breast cancers. Over half of cancer patients in the Cambridge region take part in clinical trials - the highest proportion of patients in trials across the UK.

Cancer treatment and care
The diagnosis, treatment and support for cancer patients is provided by Addenbrooke’s Hospital, where around 90 clinical consultants are members of the CRUK Cambridge Centre.
Early phase trials
Cambridge has the highest proportion of cancer patients taking part in clinical trials. These trials will benefit patients in terms of earlier detection and diagnosis, more effective treatments and improved care.
Early phase trials
Clinical research
Cambridge is the regional referral centre for breast, ovarian, prostate, pancreatic, renal, and lung cancers (at Royal Papworth Hospital). Innovative research by Cambridge scientists is improving patient treatment and care.
Clinical research

Subscribe to Centre News Latest news from the CRUK Cambridge Centre

Professor Carlos Caldas, Director of CRUK Cambridge Centre Breast Programme
Cambridge first UK centre to be given ‘Comprehensive Cancer Center of Excellence’ status by European academy.
Dr Meri Huch
Cambridge researchers in 5 shortlisted project teams competing for £20 Cancer Research UK Grand Challenge funding awards.
Professor Greg Hannon
Studies on mice show that diet changes alongside drug treatment could stop breast cancer spreading.